Lifespot Health Limited has deployed Australian and International resources to further develop and complete the BodyTelTM APP and platform extension to incorporate temperature monitoring via the Bodytel platform and a branded Bluetooth thermometer. The Company notes that the COVID-19 at risk patients can be those with Cardiovascular Disease or Diabetes. The Bodytel® System already has the capability to track blood sugar, ECG, blood pressure and weight via the existing Bluetooth connected devices. Extending the platform to track fever via body temperature is commercially low risk, yet logical extension to the platform and can currently address the large unmet need globally for this function arising from the COVID-19 pandemic.